Stock listing
NSE:POLYMED Poly Medicure Limited Share Price
Home listing (NSE) of Poly Medicure Limited
Follow Poly Medicure Limited into a list and get an email when it puts out news.
Share price · NSE:POLYMED
₹1,635.70 INR -18.80 (-1.1%)
Close on Nov 20, 2026
- Day range
- ₹1,630.60 – ₹1,669.90 INRNov 20, 2026
- Volume
- 37,528 sharesNov 20, 2026
- Market cap
- ₹165.8B INRAt the close on Nov 20, 2026 · price × 101.4M shares outstanding
- 52-week range
- ₹1,182.00 – ₹2,024.00 INRLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- ₹179.4M INRMedian day 87,034 shares · 2 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NSE:POLYMED · Home | ₹1,635.70 INR | -18.80 (-1.1%) | 37,528 | ₹1,660.10 | ₹1,669.90 | ₹1,630.60 | ₹1,654.50 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NSE:POLYMED · INR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| ₹1,635.70 | -18.80 | -1.1% | ₹1,660.10 | ₹1,669.90 | ₹1,630.60 | 37,528 | |
| ₹1,654.50 | +4.90 | +0.3% | ₹1,640.10 | ₹1,686.20 | ₹1,640.10 | 55,639 | |
| ₹1,649.60 | -34.70 | -2.1% | ₹1,681.00 | ₹1,687.20 | ₹1,640.10 | 29,322 | |
| ₹1,684.30 | +3.10 | +0.2% | ₹1,680.00 | ₹1,695.80 | ₹1,652.10 | 39,923 | |
| ₹1,681.20 | -11.90 | -0.7% | ₹1,682.00 | ₹1,690.00 | ₹1,658.20 | 30,618 | |
| ₹1,693.10 | +19.70 | +1.2% | ₹1,676.60 | ₹1,705.60 | ₹1,660.30 | 83,735 | |
| ₹1,673.40 | +59.10 | +3.7% | ₹1,616.00 | ₹1,682.80 | ₹1,612.10 | 115,635 | |
| ₹1,614.30 | +2.00 | +0.1% | ₹1,590.10 | ₹1,624.80 | ₹1,578.10 | 44,169 | |
| ₹1,612.30 | +10.10 | +0.6% | ₹1,602.20 | ₹1,630.00 | ₹1,542.40 | 135,992 | |
| ₹1,602.20 | +15.40 | +1.0% | ₹1,605.00 | ₹1,660.70 | ₹1,566.00 | 303,257 | |
| ₹1,586.80 | +90.60 | +6.1% | ₹1,494.00 | ₹1,616.00 | ₹1,480.10 | 104,894 | |
| ₹1,496.20 | +9.30 | +0.6% | ₹1,486.90 | ₹1,504.90 | ₹1,471.90 | 40,566 | |
| ₹1,486.90 | +37.40 | +2.6% | ₹1,450.10 | ₹1,495.30 | ₹1,443.40 | 57,461 | |
| ₹1,449.50 | -12.40 | -0.8% | ₹1,462.30 | ₹1,478.60 | ₹1,432.60 | 68,606 | |
| ₹1,461.90 | -14.10 | -1.0% | ₹1,480.00 | ₹1,480.20 | ₹1,446.10 | 36,087 | |
| ₹1,476.00 | +6.00 | +0.4% | ₹1,465.00 | ₹1,489.90 | ₹1,454.90 | 73,752 | |
| ₹1,470.00 | +26.50 | +1.8% | ₹1,443.50 | ₹1,473.50 | ₹1,401.50 | 32,118 | |
| ₹1,443.50 | -0.50 | 0.0% | ₹1,450.00 | ₹1,460.80 | ₹1,426.50 | 43,418 | |
| ₹1,444.00 | -4.90 | -0.3% | ₹1,441.70 | ₹1,455.80 | ₹1,403.20 | 86,154 | |
| ₹1,448.90 | -21.20 | -1.4% | ₹1,464.90 | ₹1,517.80 | ₹1,431.50 | 195,822 | |
| ₹1,470.10 | -80.60 | -5.2% | ₹1,545.00 | ₹1,554.00 | ₹1,455.10 | 197,058 | |
| ₹1,550.70 | -43.10 | -2.7% | ₹1,594.90 | ₹1,594.90 | ₹1,543.00 | 55,799 | |
| ₹1,593.80 | +10.00 | +0.6% | ₹1,578.80 | ₹1,601.10 | ₹1,575.10 | 45,455 | |
| ₹1,583.80 | -5.50 | -0.3% | ₹1,589.90 | ₹1,614.90 | ₹1,575.90 | 50,933 | |
| ₹1,589.30 | -10.70 | -0.7% | ₹1,600.00 | ₹1,608.40 | ₹1,575.50 | 68,558 | |
| ₹1,600.00 | -41.20 | -2.5% | ₹1,630.00 | ₹1,630.00 | ₹1,596.00 | 77,984 | |
| ₹1,641.20 | +54.10 | +3.4% | ₹1,599.00 | ₹1,649.90 | ₹1,582.10 | 54,472 | |
| ₹1,587.10 | -18.10 | -1.1% | ₹1,596.00 | ₹1,617.60 | ₹1,545.60 | 87,914 | |
| ₹1,605.20 | -9.80 | -0.6% | ₹1,609.80 | ₹1,624.90 | ₹1,584.30 | 81,847 | |
| ₹1,615.00 | -18.80 | -1.2% | ₹1,635.00 | ₹1,641.00 | ₹1,599.50 | 114,735 | |
| ₹1,633.80 | +14.20 | +0.9% | ₹1,613.00 | ₹1,639.90 | ₹1,611.20 | 94,082 | |
| ₹1,619.60 | -18.50 | -1.1% | ₹1,630.00 | ₹1,639.10 | ₹1,595.10 | 126,764 | |
| ₹1,638.10 | 0.00 | 0.0% | ₹1,638.10 | ₹1,638.10 | ₹1,638.10 | 0 | |
| ₹1,638.10 | -35.70 | -2.1% | ₹1,662.10 | ₹1,662.20 | ₹1,620.10 | 91,694 | |
| ₹1,673.80 | +29.10 | +1.8% | ₹1,639.90 | ₹1,684.50 | ₹1,625.80 | 118,032 | |
| ₹1,644.70 | +8.00 | +0.5% | ₹1,636.70 | ₹1,668.50 | ₹1,626.80 | 168,312 | |
| ₹1,636.70 | -87.70 | -5.1% | ₹1,724.40 | ₹1,724.40 | ₹1,611.20 | 216,866 | |
| ₹1,724.40 | +8.40 | +0.5% | ₹1,714.90 | ₹1,733.80 | ₹1,708.50 | 52,539 | |
| ₹1,716.00 | -10.60 | -0.6% | ₹1,720.10 | ₹1,772.00 | ₹1,710.10 | 114,079 | |
| ₹1,726.60 | +27.60 | +1.6% | ₹1,699.90 | ₹1,734.00 | ₹1,699.90 | 66,841 | |
| ₹1,699.00 | -7.20 | -0.4% | ₹1,715.40 | ₹1,728.00 | ₹1,695.50 | 59,651 | |
| ₹1,706.20 | -19.80 | -1.1% | ₹1,728.00 | ₹1,728.00 | ₹1,695.10 | 72,056 | |
| ₹1,726.00 | +13.30 | +0.8% | ₹1,705.70 | ₹1,748.00 | ₹1,704.50 | 150,328 | |
| ₹1,712.70 | +8.10 | +0.5% | ₹1,700.10 | ₹1,753.00 | ₹1,700.10 | 93,343 | |
| ₹1,704.60 | 0.00 | 0.0% | ₹1,701.90 | ₹1,716.70 | ₹1,691.20 | 116,363 | |
| ₹1,704.60 | -33.90 | -1.9% | ₹1,738.50 | ₹1,738.50 | ₹1,695.50 | 49,164 | |
| ₹1,738.50 | 0.00 | 0.0% | ₹1,738.50 | ₹1,738.50 | ₹1,738.50 | 0 | |
| ₹1,738.50 | -9.20 | -0.5% | ₹1,740.10 | ₹1,741.20 | ₹1,709.70 | 69,913 | |
| ₹1,747.70 | +23.70 | +1.4% | ₹1,720.30 | ₹1,757.00 | ₹1,719.00 | 99,923 | |
| ₹1,724.00 | -6.10 | -0.4% | ₹1,732.60 | ₹1,750.40 | ₹1,720.10 | 75,116 | |
| ₹1,730.10 | +29.00 | +1.7% | ₹1,700.30 | ₹1,751.00 | ₹1,682.30 | 127,092 | |
| ₹1,701.10 | -1.40 | -0.1% | ₹1,705.00 | ₹1,767.80 | ₹1,695.10 | 193,636 | |
| ₹1,702.50 | -66.20 | -3.7% | ₹1,760.00 | ₹1,774.90 | ₹1,690.10 | 171,700 | |
| ₹1,768.70 | -15.10 | -0.8% | ₹1,808.80 | ₹1,808.80 | ₹1,748.10 | 142,292 | |
| ₹1,783.80 | +27.40 | +1.6% | ₹1,750.00 | ₹1,858.00 | ₹1,739.60 | 744,104 | |
| ₹1,756.40 | -3.20 | -0.2% | ₹1,754.90 | ₹1,765.00 | ₹1,721.60 | 180,195 | |
| ₹1,759.60 | +26.60 | +1.5% | ₹1,730.10 | ₹1,803.00 | ₹1,706.50 | 283,673 | |
| ₹1,733.00 | +20.40 | +1.2% | ₹1,707.20 | ₹1,741.00 | ₹1,681.70 | 197,416 | |
| ₹1,712.60 | +1.40 | +0.1% | ₹1,712.00 | ₹1,727.50 | ₹1,682.30 | 109,590 | |
| ₹1,711.20 | -20.50 | -1.2% | ₹1,727.40 | ₹1,756.90 | ₹1,706.40 | 91,740 | |
| ₹1,731.70 | -5.50 | -0.3% | ₹1,737.10 | ₹1,753.00 | ₹1,713.00 | 78,354 | |
| ₹1,737.20 | +17.80 | +1.0% | ₹1,705.00 | ₹1,769.90 | ₹1,705.00 | 95,827 | |
| ₹1,719.40 | -50.20 | -2.8% | ₹1,771.00 | ₹1,783.80 | ₹1,710.00 | 96,900 | |
| ₹1,769.60 | -0.70 | 0.0% | ₹1,775.00 | ₹1,784.80 | ₹1,756.00 | 93,919 |
Splits
3 splits since 2013 · NSE:POLYMED · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 2-for-1 | Split | |
| 2-for-1 | Split | |
| 2-for-1 | Split |
- Ticker
- NSE:POLYMED
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- NSE
- Currency
- INR
What changed lately
Latest earnings call · Nov 5, 2026
Poly Medicure (NSE:POLYMED) Q2 2027 Earnings Call
Replay and transcript
Latest deck · Nov 5, 2026
Q2 FY2027 Earnings Presentation
Earnings · 34 slides
Latest news
Poly Medicure Limited on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 6 in all · newest Sep 24, 2025 · oldest 2025
- Calls
- 2 calls with a replay · 2 with a transcript · latest Nov 5, 2026
- Decks
- 34 decks · latest Nov 5, 2026
Where Poly Medicure Limited is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NSE:POLYMED · Home listing · This page | NSE | India | INR |
| BSE:POLYMED | BSE | India | INR |
Valuation
P/E 52.1× against a median of 18.2×: 7th lowest of 8 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- ₹157.9B INR
- P/E
- 52.1×
- EV/sales
- 7.4×
- EV/EBITDA
- 32.6×
- Price/book
- 5.1×
- Gross margin
- 47.6%
- Operating margin
- 16.2%
- Net margin
- 14.9%
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Poly Medicure Limited · NSE:POLYMED | US$1.79B | US$1.70B | 52.1× | 7.4× | 32.6× | 5.1× | 14.9% | 0.0× | n/a |
| Establishment Labs Holdings Inc. · NASDAQ:ESTA | US$2.06B | US$2.25B | n/a | 8.5× | n/a | 132× | −14.6% | 17.2× | 1.29 |
| Heron Neutron Medical Corp. · TWSE:7799 | US$1.96B | US$1.67B | n/a | 5,350× | n/a | 5.8× | n/a | 0.0× | n/a |
| Shandong Weigao Group Medical Polymer Co. Ltd. Class H · HKEX:1066 | US$1.80B | US$1.20B | 7.4× | 0.6× | 3.0× | 0.5× | 12.0% | 0.2× | n/a |
| Top Glove Corporation Bhd. · MYX:TOPGLOV | US$1.79B | US$1.75B | 23.8× | 1.7× | 9.9× | 1.5× | 7.3% | 0.2× | n/a |
| Embla Medical hf · OMXCOP:EMBLA | US$1.71B | US$2.12B | 18.2× | 2.1× | 10.4× | 1.8× | 9.5% | 0.5× | n/a |
| Medartis Holding AG · SIX:MED | US$1.69B | US$1.91B | 170× | 6.0× | 58.5× | 5.0× | 3.1% | 0.7× | n/a |
| LeMaitre Vascular, Inc. · NASDAQ:LMAT | US$1.68B | US$1.48B | 26.6× | 5.5× | 17.4× | 3.9× | 23.5% | 0.4× | 0.58 |
| Dentsply Sirona Inc. · NASDAQ:XRAY | US$1.65B | US$3.44B | n/a | 1.0× | 12.1× | 1.2× | −3.4% | 1.5× | 1.03 |
| Angelalign Technology Inc. · HKEX:6699 | US$1.60B | −US$354.3M | 5.7× | −0.1× | −0.7× | 0.6× | 9.3% | 0.2× | n/a |
| Inspire Medical Systems, Inc. · NYSE:INSP | US$1.60B | US$1.27B | 15.8× | 1.4× | 36.9× | 1.9× | 11.4% | 0.0× | 1.00 |
| Median of the others | US$1.70B | US$1.71B | 18.2× | 1.9× | 11.3× | 1.9× | 9.3% | 0.3× | 1.02 |
Forecasts
Analysts' consensus from EODHD, read Nov 9, 2026. Not 6ix's view and not investment advice.
- Price target
- 1858.17 INR · Analysts' mean
- EPS, year to Mar 2027
- 40.60 · 6 analysts
- Revenue, year to Mar 2027
- 23.75B · 5 analysts
Team and board
| Officer | Role |
|---|---|
| Himanshu Baid | Managing Director |
Events
Calls
| Call | When | Status |
|---|---|---|
| Poly Medicure (NSE:POLYMED) Q2 2027 Earnings Call | Thu, Nov 05, 2026 · 8:52 AM ET | Replay |
| Poly Medicure (NSE:POLYMED) Q1 2027 Earnings Call | Mon, Aug 10, 2026 · 9:48 AM ET | Replay |
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q2 2027 | Nov 5, 2026 · Before open | +1.0% |
| Q1 2027 | Aug 7, 2026 · Before open | −0.9% |
| Q4 2026 | May 25, 2026 · Before open | −3.2% |
| Q3 2026 | Feb 5, 2026 · Before open | −1.0% |
| Q2 2026 | Nov 8, 2025 · Before open | −1.7% |
| Q1 2026 | Aug 8, 2025 · Before open | −0.5% |
| Q4 2025 | May 6, 2025 · After close | +1.9% |
| Q3 2025 | Feb 3, 2025 · Before open | −6.2% |
| Q2 2025 | Oct 28, 2024 · Before open | +4.4% |
| Q1 2025 | Jul 22, 2024 · Before open | −1.4% |
All 19 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q3 2024 | Jan 31, 2024 · Before open | +4.8% |
| Q2 2024 | Nov 4, 2023 · Before open | −6.2% |
| Q1 2024 | Aug 7, 2023 · Before open | +14.5% |
| Q4 2023 | May 9, 2023 · Before open | −1.3% |
| Q2 2023 | Nov 4, 2022 · Before open | +5.2% |
| Q1 2023 | Aug 4, 2022 · Before open | −2.3% |
| Quarter to Sep 30, 2021 | Nov 1, 2021 · Before open | −0.6% |
| Quarter to Jun 30, 2021 | Jul 29, 2021 · Before open | −1.9% |
| Quarter to Dec 31, 2020 | Jan 27, 2021 · Before open | −1.4% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q2 FY2027 Earnings Presentation | Earnings | 34 slides | Nov 5, 2026 |
| Q2 FY27 Earnings Presentation | Earnings | 34 slides | Nov 5, 2026 |
| Shareholder Meeting (September 2026) | Shareholder meeting | 22 slides | Sep 5, 2026 |
| Q1 FY27 Earnings Presentation | Earnings | 29 slides | Aug 7, 2026 |
| Q1 FY27 Earnings Presentation | Earnings | 30 slides | Aug 7, 2026 |
| Q4 FY26 Earnings Presentation | Earnings | 43 slides | May 25, 2026 |
| Q4 FY26 Earnings Presentation | Earnings | 42 slides | May 25, 2026 |
| Investor Presentation (March 2026) | Investor deck | 15 slides | Mar 7, 2026 |
| Q3 FY26 Earnings Presentation | Earnings | 16 slides | Feb 5, 2026 |
| Q2 FY26 Earnings Presentation | Earnings | 34 slides | Nov 8, 2025 |
All 34 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Merger or Acquisition (September 2025) | Merger or acquisition | 22 slides | Sep 25, 2025 |
| Shareholder Meeting (September 2025) | Shareholder meeting | 28 slides | Sep 25, 2025 |
| Merger or Acquisition (September 2025) | Merger or acquisition | 22 slides | Sep 24, 2025 |
| Merger or Acquisition (September 2025) | Merger or acquisition | 18 slides | Sep 3, 2025 |
| Merger or Acquisition (September 2025) | Merger or acquisition | 17 slides | September 2025 |
| Merger or Acquisition (September 2025) | Merger or acquisition | 21 slides | September 2025 |
| Q1 FY26 Earnings Presentation | Earnings | 33 slides | Aug 8, 2025 |
| Q1 FY26 Earnings Presentation | Earnings | 34 slides | Aug 8, 2025 |
| Q4 FY2025 Earnings Presentation | Earnings | 19 slides | May 6, 2025 |
| Q3 FY25 Earnings Presentation | Earnings | 19 slides | Feb 3, 2025 |
| Q2 FY2024-25 Earnings Presentation | Earnings | 10 slides | September 2024 |
| Shareholder Meeting (September 2024) | Shareholder meeting | 25 slides | September 2024 |
| Q1 FY2025 Earnings Presentation | Earnings | 25 slides | Jul 24, 2024 |
| Investor Presentation (July 2024) | Investor deck | 24 slides | July 2024 |
| Investor Presentation (May 2024) | Investor deck | 22 slides | May 17, 2024 |
| Investor Presentation (May 2024) | Investor deck | 21 slides | May 2024 |
| Q2 FY2024 Earnings Presentation | Earnings | 20 slides | Sep 30, 2023 |
| Shareholder Meeting (September 2023) | Shareholder meeting | 31 slides | September 2023 |
| Investor Presentation (May 2023) | Investor deck | 31 slides | May 2023 |
| Investor Presentation (May 2022) | Investor deck | 25 slides | May 24, 2022 |
| Investor Presentation (May 2022) | Investor deck | 24 slides | May 2022 |
| Investor Presentation (May 2021) | Investor deck | 38 slides | May 25, 2021 |
| Q3 FY2021 Earnings Presentation | Earnings | 26 slides | Feb 4, 2021 |
| Investor Presentation (August 2020) | Investor deck | 35 slides | August 2020 |
Financials
Annual, in INR
Income statement
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 18.8B | 16.7B | 13.8B | 11.2B | 9.23B | 7.86B | 6.87B | 6.11B | 5.20B | 4.55B |
| Cost of revenue | 11.1B | 5.59B | 4.87B | 4.09B | 3.51B | 2.64B | 2.19B | 2.11B | 1.67B | 1.57B |
| Gross profit | 7.61B | 11.1B | 8.89B | 7.06B | 5.72B | 5.23B | 4.68B | 4.00B | 3.54B | 2.98B |
| Research and development | 298.8M | 245.7M | 194.4M | 178.0M | 187.7M | 131.4M | 119.4M | 101.5M | 100.5M | 90.3M |
| Selling, general and administrative | 1.08B | 3.05B | 2.48B | 2.05B | 1.66B | 1.44B | 1.40B | 1.19B | 1.01B | 887.4M |
| Operating income | 3.27B | 7.76B | 6.18B | 4.81B | 3.87B | 3.65B | 3.13B | 2.68B | 2.40B | 1.96B |
| Depreciation and amortization | 1.16B | 831.8M | 639.3M | 571.7M | 539.5M | 475.2M | 405.3M | 372.9M | 292.4M | 237.3M |
| EBITDA | 4.42B | 8.59B | 6.82B | 5.38B | 4.40B | 4.12B | 3.53B | 3.05B | 2.69B | 2.20B |
| Interest expense | 182.9M | 140.0M | 130.5M | 81.9M | 57.4M | 90.8M | 120.1M | 136.7M | 109.7M | 85.5M |
| Income before tax | 4.27B | 4.53B | 3.44B | 2.37B | 1.95B | 1.80B | 1.26B | 1.00B | 967.5M | 751.9M |
| Income tax | 1.07B | 1.14B | 860.1M | 582.1M | 487.4M | 441.8M | 298.5M | 346.8M | 261.6M | 200.6M |
| Net income | 3.22B | 3.39B | 2.58B | 1.79B | 1.47B | 1.36B | 958.8M | 654.0M | 705.9M | 551.3M |
| Earnings per share, basic | 31.75 | 34.11 | 26.90 | 18.67 | 15.27 | 15.24 | 10.86 | 7.41 | 8.00 | 6.25 |
Balance sheet
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 878.7M | 1.51B | 120.5M | 70.6M | 77.6M | 49.5M | 48.6M | 43.2M | 37.0M | 226.2M |
| Short-term investments | 7.39B | 10.6B | 2.74B | 2.94B | 3.44B | 3.69B | 361.1M | 503.2M | 271.6M | 238.3M |
| Receivables | 5.32B | 3.50B | 2.70B | 2.43B | 2.07B | 1.56B | 1.36B | 1.43B | 1.39B | -20.2M |
| Inventory | 4.34B | 2.86B | 2.21B | 2.09B | 1.68B | 1.26B | 1.12B | 837.9M | 729.9M | 639.3M |
| Current assets | 19.4B | 19.2B | 8.42B | 8.07B | 7.83B | 7.06B | 3.18B | 3.02B | 2.55B | 2.05B |
| Property, plant and equipment | 11.3B | 8.89B | 6.62B | 4.77B | 3.91B | 3.32B | 2.70B | 2.58B | 2.06B | |
| Goodwill | 2.74B | 285.8M | 285.8M | 285.8M | 285.8M | 285.8M | 285.8M | 285.8M | ||
| Total assets | 39.2B | 31.9B | 18.6B | 15.8B | 13.8B | 12.2B | 7.67B | 6.54B | 5.65B | 4.55B |
| Accounts payable | 1.23B | 864.2M | 956.0M | 923.1M | 890.4M | 645.2M | 663.6M | 555.4M | 436.2M | 418.6M |
| Current liabilities | 5.76B | 3.70B | 3.51B | 2.93B | 2.27B | 1.71B | 1.97B | 1.54B | 1.23B | 1.19B |
| Long-term debt | 520.9M | 0 | 10.9M | 175.0M | 381.3M | 632.8M | 1.11B | 911.2M | 782.9M | 463.1M |
| Total debt | 3.54B | 1.80B | 1.74B | 1.49B | 1.27B | 1.37B | 2.07B | 1.61B | 1.33B | 799.9M |
| Total liabilities | 7.69B | 4.27B | 3.89B | 3.36B | 2.89B | 2.58B | 3.33B | 2.73B | 2.27B | 1.90B |
| Shareholders' equity | 31.1B | 27.7B | 14.7B | 12.4B | 10.9B | 9.66B | 4.35B | 3.81B | 3.38B | 2.64B |
| Shares outstanding | 101.5M | 99.2M | 96.0M | 96.0M | 96.0M | 89.2M | 88.3M | 88.2M | 88.2M | 88.2M |
Cash flow
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 2.48B | 2.40B | 2.66B | 1.91B | 1.23B | 1.19B | 1.31B | 1.07B | 749.3M | 561.2M |
| Capital spending | -3.08B | -3.31B | -2.77B | -2.39B | -1.56B | -951.3M | -1.06B | -780.0M | -824.6M | -586.1M |
| Free cash flow | -601.7M | -906.1M | -109.3M | -484.5M | -321.1M | 236.0M | 244.8M | 291.3M | -75.3M | -24.9M |
| Cash from investing | -2.43B | -11.9B | -2.41B | -1.79B | -853.3M | -4.36B | -1.07B | -1.02B | -880.0M | -618.0M |
| Cash from financing | 361.4M | 9.51B | -201.5M | -125.1M | -353.4M | 3.17B | -205.1M | -45.9M | 157.1M | -2.89M |
| Dividends paid | -354.3M | -303.4M | -287.4M | -239.7M | -239.2M | -239.2M | -424.7M | -211.9M | -53.1M | -132.7M |
| Share buybacks | 10.0B | 2.64M | 3.51M | 989.0K | 4.00B | 503.0K | -282.4M | |||
| Change in cash | 787.1M | -33.5M | 49.9M | -6.95M | 28.0M | 972.0K | 5.40M | 6.17M | 26.4M | -59.7M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| Press Release Sep 24 2025 | Sep 24, 2025 | Acquisition or disposal | NSE India |
| Press Release Sep 03 2025 | Sep 3, 2025 | Acquisition or disposal | NSE India |
| Press Release Aug 08 2025 | Aug 8, 2025 | Results | NSE India |
| Press Release May 06 2025 | May 6, 2025 | Results | NSE India |
| Press Release Feb 03 2025 | Feb 3, 2025 | Results | NSE India |
Cap table
Built by 6ix from Poly Medicure Limited’s releases
- Common shares
- 101,361,465
- Fully diluted
- 101,361,465
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 101,361,465 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 101,361,465 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Himanshu Baid | Managing Director · Since at least Aug 7, 2025 |
Log in to ask 6ix AI your own questions about Poly Medicure Limited.